|Bid||28.03 x 1100|
|Ask||28.06 x 900|
|Day's range||27.97 - 28.10|
|52-week range||26.92 - 28.85|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||2.59|
|Forward dividend & yield||1.72 (6.16%)|
|Ex-dividend date||05 Aug 2021|
|1y target est||N/A|
NEW YORK, October 14, 2021--Please view Citi’s third quarter 2021 earnings press release on its website http://www.citigroup.com/citi/investor.
NEW YORK & LONDON & HONG KONG, October 11, 2021--Settlement compression continues as one of the most pressing issues for the equities post trade industry, with the planned transition to T+1 in the U.S., together with the recent global volatility spikes. A new global study "Securities Services Evolution" by Citi Securities Services, shows that 44% of market participants surveyed expect the prevailing settlement timeframe for equities to be T+1 within the next five years.
LONDON, October 06, 2021--Citi, acting through Citibank N.A., has been appointed by Exscientia plc ("Exscientia"), an AI-driven pharmatech company committed to designing and developing the best possible drugs in the fastest and most effective manner, to act as depositary bank for its American Depositary Receipt ("ADR") programme.